Daily News for Dealmakers
Before Mr. Musk renewed his $44 billion proposal, he and the company haggled in discussions that ultimately did not advance.
Source
Author: Kate Conger and Michael S. Schmidt
Strategic Acquisition: AbbVie's $1.4 billion acquisition of Aliada Therapeutics signals a significant bet on Alzheimer's disease treatment, bolstering its pipeline with a Phase I anti-amyloid...
Antitrust Scrutiny: The blocked $8.5 billion Tapestry-Capri merger highlights increasing antitrust scrutiny in the luxury fashion industry, as regulators aim to protect consumer interests and...
Regulatory Hurdles: Carlyle Group's withdrawal from bidding for Thyssenkrupp's defence unit highlights the significant regulatory challenges in Germany's defence industry M&A landscape. Strategic...
Strategic Acquisition: Boeing's $4.7 billion all-stock acquisition of Spirit AeroSystems aims to improve aircraft quality and safety by integrating Spirit's operations. Regulatory Scrutiny: The...